{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T18:03:12Z","timestamp":1780941792657,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.aohep.2020.08.070","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T12:04:59Z","timestamp":1600257899000},"page":"100253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"20","author":[{"given":"Jos\u00e9 Tadeu","family":"Stefano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Vilar","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Alencar Arrais","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Siqueira","family":"Vanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ven\u00e2ncio Avancini Ferreira","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flair Jos\u00e9","family":"Carrilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Largura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Arrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia P.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2020.08.070_bib0005","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2020.08.070_bib0010","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.08.070_bib0015","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2020.08.070_bib0020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"easloffice@easloffice.eu EAftSotLEa, Liver EAftSot. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2020.08.070_bib0025","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.08.070_bib0030","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2020.08.070_bib0035","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.3748\/wjg.v12.i23.3682","article-title":"Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy","volume":"12","author":"Sebastiani","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2020.08.070_bib0040","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.08.070_bib0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/TROG_20103103_199","article-title":"Percutaneous liver biopsy","volume":"31","author":"Rustagi","year":"2010","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.aohep.2020.08.070_bib0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2020.08.070_bib0055","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1478-3231.2007.01592.x","article-title":"Percutaneous liver biopsy in clinical practice","volume":"27","author":"Al Knawy","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2020.08.070_bib0060","doi-asserted-by":"crossref","first-page":"899","DOI":"10.5604\/01.3001.0012.7188","article-title":"The evolving role of liver biopsy in non-alcoholic fatty liver disease","volume":"17","author":"Arab","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2020.08.070_bib0065","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.08.070_bib0070","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"Loomba","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2020.08.070_bib0075","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/liv.12240","article-title":"Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis","volume":"33","author":"Bota","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2020.08.070_bib0080","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.08.070_bib0085","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc20-Sint","article-title":"American diabetes association standards of medical care in diabetes - 2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.aohep.2020.08.070_bib0090","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.aohep.2020.08.070_bib0095","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2020.08.070_bib0100","unstructured":"Eng J. ROC analysis: web-based calculator for ROC curves. In. Baltimore: Johns Hopkins University [updated 2014 March 19; cited <date>]. Available from: http:\/\/www.jrocfit.org."},{"key":"10.1016\/j.aohep.2020.08.070_bib0105","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.aohep.2020.08.070_bib0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.08.070_bib0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.08.070_bib0120","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2020.08.070_bib0125","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.08.070_bib0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2020.08.070_bib0135","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/MEG.0b013e32835d72cf","article-title":"Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?","volume":"25","author":"McPherson","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2020.08.070_bib0140","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.aohep.2020.08.070_bib0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/hepr.12710","article-title":"Classification of patients with non-alcoholic fatty liver disease using rapid immunoassay of serum type IV collagen compared with liver histology and other fibrosis markers","volume":"47","author":"Mizuno","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.aohep.2020.08.070_bib0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00535-017-1355-9","article-title":"A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis","volume":"53","author":"Okanoue","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.aohep.2020.08.070_bib0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.26030","article-title":"Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease","volume":"57","author":"Tanwar","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.aohep.2020.08.070_bib0160","first-page":"203","article-title":"High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases","volume":"12","author":"Gudowska","year":"2017","journal-title":"Prz Gastroenterol"},{"key":"10.1016\/j.aohep.2020.08.070_bib0165","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.trsl.2009.06.007","article-title":"Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease","volume":"154","author":"Miele","year":"2009","journal-title":"Transl Res"},{"key":"10.1016\/j.aohep.2020.08.070_bib0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1751-2980.2009.00386.x","article-title":"Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis","volume":"10","author":"Lesmana","year":"2009","journal-title":"J Dig Dis"},{"key":"10.1016\/j.aohep.2020.08.070_bib0175","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.13787","article-title":"Hyaluronic Acid: from biochemical characteristics to its clinical translation in assessment of liver fibrosis","volume":"13","author":"Rostami","year":"2013","journal-title":"Hepat Mon"},{"key":"10.1016\/j.aohep.2020.08.070_bib0180","series-title":"Liver biopsy","first-page":"343","article-title":"Comparison of Five liver fibrosis indexes with serum levels of laminin and N terminal peptide of procollagen type III in chronic hepatitis patients","author":"Parsian","year":"2011"},{"key":"10.1016\/j.aohep.2020.08.070_bib0185","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2020.08.070_bib0190","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/hepr.13226","article-title":"Accuracy of non-invasive scoring systems for diagnosing non-alcoholic steatohepatitis-related fibrosis: multicenter validation study","volume":"48","author":"Itoh","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.aohep.2020.08.070_bib0195","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/MEG.0000000000001079","article-title":"Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina","volume":"30","author":"Valva","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2020.08.070_bib0200","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12876-019-1039-4","article-title":"Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease","volume":"19","author":"Srivastava","year":"2019","journal-title":"BMC Gastroenterol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812030168X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812030168X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:40:55Z","timestamp":1761648055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S166526812030168X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":40,"alternative-id":["S166526812030168X"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2020.08.070","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2020.08.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100253"}}